ÅǸ޴º
Á¦¸ñ | Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the 2nd line chemotherapy for patients with metastatic pancreatic cancer; multicenter study of the Korean Cancer Study Group (KCSG) (ASCO Annual Meeting, Virtual, 2020) | µî·ÏÀÏ | 20200923 | ´Ù¿î·Îµå | |
---|---|---|---|---|---|
Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the 2nd line chemotherapy for patients with metastatic pancreatic cancer; multicenter study of the Korean Cancer Study Group (KCSG) (ASCO Annual Meeting, Virtual, 2020)
|
Copyright ¨Ï chamc, All rights reserved.